Long-Acting ??2-Agonists or Leukotriene Receptor Antagonists as Add-On Therapy to Inhaled Corticosteroids for the Treatment of Persistent Asthma
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 63 (2) , 21-33
- https://doi.org/10.2165/00003495-200363002-00003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Long-acting beta2-agonists versus theophylline for maintenance treatment of asthmaPublished by Wiley ,2003
- The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthmaRespiratory Medicine, 2003
- Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthmaRespiratory Medicine, 2002
- Two-Year Retrospective Economic Evaluation of Three Dual-Controller Therapies Used in the Treatment of AsthmaChest, 2002
- Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trialThe Lancet, 2001
- Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukastJournal of Allergy and Clinical Immunology, 2000
- What are minimal important changes for asthma measures in a clinical trial?European Respiratory Journal, 1999
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Lung Function Testing: Selection of Reference Values and Interpretative StrategiesAmerican Review of Respiratory Disease, 1991